bluebird bio, Inc. (BLUE) - Cash Funds Calculated per Share

Symbol and logo of brand bluebird bio, Inc (BLUE)

Cash per share trends on the GURU.Markets terminal chart demonstrate the issuer's liquidity, where 8.01 serves as the final level mark. The rise in bluebird bio, Inc. (BLUE) quotes is supported by the expansion of insurance coverage and sales of Lyfgenia and Zynteglo. The company corrects defective cells in a single session, offering a revolutionary treatment method. The current product portfolio ensures commercial development in anemia therapy.

Bluebird Bio - BLUE Cash per Share (period 07/04/2022 - 06/07/2025)

Comprehensive metric breakdowns and analytics for bluebird bio (BLUE)

- cash and cash flow data:
Comprehensive company analysis:bluebird bio, Inc.
Manufactured product of bluebirdbio.com

bluebird bio, Inc. (BLUE) holds a leading position in the gene therapy sector, possessing exceptional pricing power. This indicator determines the volume of liquid assets per common share, reflecting the actual financial reserve. By analyzing the cash per share calculation, an investor assesses the business's ability to sustain operational activities. The company's high gross margin ensures a steady inflow of capital. Such a foundation confirms the long-term sustainability of the business.

Competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology